Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

Aurore Morello

Research Scholar

Office Phone

212-639-8158

Start Year

2013

Publications

Manuscripts

Abstracts/Presentations

  • Morello A, Chen N, Cherkassky L, Sadelain M, Jones DR, Adusumilli PS. Converting tumor-mediated PD-L1 inhibition into CAR T-cell costimulation to potentiate thoracic cancers immunotherapy. International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. December 4-7, 2016; Vienna, Austria.
  • Morello A, Zeltsman M, Bograd A, Jones DR, Adusumilli PS. Mechanistic insights into CAR T-cell efficacy in the treatment of heterogenous antigen expressing lung adenocarcinoma. International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. December 4-7, 2016; Vienna, Austria.
  • Morello A, Villena-Vargas J, Mayor M, Bograd AJ, Jones DR, Sadelain M,  Adusumilli PS. Mesothelin-Targeted CAR T-Cell Therapy for the Treatment of Heterogeneous Antigen-Expressing Lung Adenocarcinoma. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Mayor M, Villena-Vargas J, de Biasi A, Morello A, Jones DR, Sadelain M, Adusumilli PS. Tumor-Targeted Radiation Therapy Helps Overcome the Solid Tumor T-Cell Infiltration Barrier and Promotes Mesothelin CAR T-Cell Therapy. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Eguchi T, Ujiie H, Morello A, Kadota K, Buitrago DH, Woo K, Jones DR, Travis WD, Sadelain M, Adusumilli PS. Mesothelin and MUC16 (CA125) Are Antigen-Targets for CAR T-Cell Therapy in Primary and Metastatic Lung Adenocarcinoma. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Cherkassky L, Morello A, Villena-Vargas J, Mayor M, Jones DR, Sadelain M, Adusumilli PS. Genetic-Engineering Strategies to Enhance CAR T-Cell Therapy Efficacy against PD-L1 Expressing Lung Adenocarcinoma and Mesothelioma. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Roldan C, Morello A, Adusumilli PS. Immunotherapeutic T-cell engineering techniques targeting solid tumors. 37th Annual Memorial Sloan-Kettering Cancer Center Medical Student Summer Fellowship Program Poster Presentation. August 14, 2014; New York, NY.